Subscribe to receive future Ambry updates!
Ambry Genetics Launches BRCA 1 & 2: Single Genes and NGS Panel Offerings
CEOCFO Magazine Interview with Charles Dunlop
Ambry Genetics Leading the Way With Clinical Next-Generation Sequencing
Somatic Mutation Analysis
Milestone: 10,000 Diagnostic & 100,000 Genomic NGS Samples
Diagnosing Rare Disorders Using Next Generation Sequencing
Ambry Genetics Chairman and CEO Charles Dunlop Honored with RARE Champion Award at Global Genes Project’s Champions of Hope Gala
The Clinical Exome: The Brass Ring of Molecular Testing?
Ambry Genetics Catches the Clinical Sequencing Wave
Ernst & Young announces finalists for the 2012 Entrepreneur of the Year Awards in Orange County
Start your search...